InterVene, Inc. is excited to join a select group of medical device companies presenting innovative technologies at #TheVEINS24 Innovation Summit in Las Vegas this Sunday (11/3/2024). Kush Desai, MD will present InterVene's #Recana (formerly Chronus) system, currently in development for recanalizing chronic and postthrombotic (PT) venous occlusion and obstruction. Recana's design facilitates treatment in cases of chronic in-stent restenosis (ISR) and late percutaneous mechanical thrombectomy (PMT) for chronic tissue and obstructed and occluded venous stents. Dr. Desai takes the stage from 7:22-7:33 am during the Blue Sky Breakfast. Hope to see you there! #VIVA24 #chronicvenousinsufficiency #CVI #deepvenousstenting #deepveinthrombosis #DVT Jeff Elkins Catherine Matthes Jay Schmelter Andrew Kleiboeker
InterVene, Inc.
医疗设备制造业
Redwood City,California 1,396 位关注者
Developing interventional technologies to treat and prevent severe, complex venous diseases
关于我们
- 网站
-
https://intervene-med.com/
InterVene, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Redwood City,California
- 类型
- 私人持股
- 创立
- 2012
地点
-
主要
US,California,Redwood City,94063